Physician profile
Prashant Rupapara
NPI 1184075848
$506.85
in general payments reported to CMS, 2019-2025
9 companies · $212 in 2025
The $212 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.02 · 2021: $42.11 · 2022: $91.16 · 2023: $14.64 · 2024: $76.77 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $200 · Food and Beverage: $89.20 · Entertainment: $14.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $200.00 |
| Food and Beverage | $89.20 |
| Entertainment | $14.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Purelife, LLC | $200.00 | 2025 | |
| Straumann USA LLC | $113.10 | 2022-2024 | |
| Henry Schein, INC. | $58.48 | 2019 | |
| Implant Direct Sybron International LLC | $53.65 | 2019-2021 | |
| Dentsply Sirona INC | $28.35 | 2023-2024 | Disposa-Shield |
| Coltene Whaledent INC. | $14.36 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $13.46 | 2022 | |
| Philips North America LLC | $13.30 | 2024 | (E55) Oral Health Care Und |
| Voco America INC. | $12.15 | 2025 | Grandio So Flow, Meron Plus Qm, Admira Fusion X-Tra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashant Rupapara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.